Abdominal Ultrasound: A Vital Tool for TB Diagnosis in HIV-Positive Adults
"Unlocking the potential of ultrasound in diagnosing abdominal tuberculosis, especially for those with HIV."
Tuberculosis (TB), a persistent global health challenge, often extends beyond the lungs, particularly in individuals with HIV. Diagnosing abdominal TB or disseminated TB with abdominal involvement in HIV-positive adults poses significant difficulties due to atypical presentations and the limitations of traditional diagnostic methods.
In this context, abdominal ultrasound emerges as a promising tool. It is readily accessible, relatively inexpensive, and non-invasive, making it a valuable asset in resource-limited settings where advanced imaging techniques like CT scans are not readily available. But how accurate and reliable is abdominal ultrasound for diagnosing TB in this specific population?
This article delves into a Cochrane review protocol that aims to determine the diagnostic accuracy of abdominal ultrasound, both as a standalone test and in combination with other existing tests, for detecting abdominal TB in HIV-positive adults. We'll explore the potential benefits and limitations of this imaging technique, shedding light on its role in improving TB diagnosis and treatment outcomes.
TB Burden and Ultrasound’s Role
The CDC publishes tuberculosis data to track progress toward elimination, including U.S. cases among people with HIV test results and TB-HIV coinfection from 2011 through 2024. HIV-positive people have higher rates of extrapulmonary TB, and ultrasound is widely used—including at the point of care—in evaluations for abdominal or disseminated TB. In a study of seriously ill HIV-positive inpatients, three abdominal ultrasound features independently predicted TB with moderate diagnostic performance; ultrasound was more sensitive but less specific than chest radiography in that population.
Diagnostic Challenges in HIV-Associated TB
A prospective study examined abdominal ultrasound in HIV-positive inpatients with cough and World Health Organization danger signs, addressing limitations in earlier studies of ultrasound for HIV-associated TB. More broadly, available TB laboratory diagnostic methods vary substantially in applicability, implementation, and clinical impact across healthcare settings. The supplied sources therefore describe both a focused inpatient study and wider variation in how diagnostic methods can be used in practice.
A Persistent and Re-emerging Disease
Tuberculosis has challenged societies throughout human history, with its social consequences a persistent part of the disease’s story. A global history traces milestones from ancient evidence and consumption through Koch’s identification of the bacillus, sanatoria, BCG vaccination, antibiotics, HIV, and drug resistance. Abdominal TB has re-emerged in Western populations as more HIV infections are recognized, and its varied presentations and resemblance to Crohn’s disease continue to complicate management.
The Potential of Abdominal Ultrasound in TB Diagnosis
Abdominal ultrasound offers a non-invasive way to visualize the abdominal cavity, potentially revealing signs indicative of TB. These signs can include:
- Lymphadenopathy: Enlarged lymph nodes in the abdomen.
- Ascites: Accumulation of fluid in the abdominal cavity.
- Focal lesions: Abnormalities in the liver and spleen.
- Lymphadenopathy: Enlarged lymph nodes in the abdomen.
- Ascites: Accumulation of fluid in the abdominal cavity.
- Focal lesions: Abnormalities in the liver and spleen.
Evolving Research on TB Diagnosis
A 2024 review reports that untreated HIV increases TB risk and that diagnosis and treatment remain challenging, while access to preventive therapy is limited. A 2023 evidence-based review describes tuberculous peritonitis and gastrointestinal TB as the two major forms of abdominal TB, with esophageal, gastroduodenal, pancreatic, hepatic, gallbladder, and biliary forms occurring less frequently. A 2026 review highlights evolving diagnostic research spanning molecular analysis, non-sputum-based tests, and artificial-intelligence-driven imaging.
Limits of the Evidence Base
The Cochrane review’s selection criteria included cross-sectional, cohort, and diagnostic case-control studies, whether prospective or retrospective, that compared abdominal ultrasound with a reference standard. This describes the study designs eligible for the review, rather than establishing that ultrasound alone can confirm abdominal or disseminated TB. The source excerpt does not provide pooled accuracy estimates or a conclusion about ultrasound’s performance.
Ultrasound Within a Diagnostic Workup
Ultrasound, including point-of-care imaging, is widely used when abdominal or disseminated TB is suspected in people with HIV, who have higher rates of extrapulmonary disease. The FASH protocol has been applied and researched for over a decade in HIV-infected patients with suspected extrapulmonary TB. However, interpreting its target features can be difficult because they may also indicate other opportunistic diseases. One diagnostic guidance source says tissue sampling by laparoscopy or percutaneous biopsy is needed for histopathology and microbiological confirmation, since ascitic-fluid analysis alone has insufficient sensitivity.
Looking Ahead: Improving TB Diagnosis for Better Outcomes
The Cochrane review protocol underscores the importance of accurate and timely TB diagnosis, particularly in vulnerable populations like HIV-positive adults. By systematically evaluating the diagnostic accuracy of abdominal ultrasound, researchers aim to provide clinicians with evidence-based guidance for its use.
Toward More Integrated TB-HIV Diagnostics
A 2026 narrative review summarizes current and emerging diagnostic approaches for TB-HIV, emphasizing diagnostic performance, clinical applicability, implementation challenges, and possible integration into future algorithms. A 2025 review describes an ideal test as a point-of-care device that can provide an on-the-spot accurate diagnosis of active TB in HIV-infected and uninfected adults and children, across pulmonary and extrapulmonary disease, while also detecting drug resistance. These are stated research goals and review themes, not evidence that such an ideal tool is already available.
Ultrasound in HIV Clinic Case Finding
Researchers analyzed routine abdominal ultrasonography as a way to support active case finding for abdominal TB in HIV clinics. They undertook the analysis after an observation and a small prospective pilot study that assessed different tests for diagnosing HIV-associated extrapulmonary TB. The source describes the study’s rationale and aim, but its excerpt does not report the results.
The review also highlights the need to consider various factors that can influence test accuracy, such as the expertise of the person performing the ultrasound and the clinical setting. Understanding these sources of heterogeneity is crucial for optimizing the application of abdominal ultrasound in different contexts.
Ultimately, this research strives to improve TB diagnosis, enabling earlier treatment initiation and better outcomes for individuals co-infected with HIV, contributing to global efforts to combat this devastating disease.